View Author
angioplasty patient lesion diameter lumen diameter follow-up restenosi event balloon lumen study balloon angioplasty analysis factor month stenosi group angiographic stent circulation angina percutaneous transluminal artery variable vessel percutaneou procedure luminal change transluminal cardiol angiography swets subs service result risk factors trial thrombu occlusion stent implantation point model process serruy table 6 months restenosis process heart implantation criterion king sb iii system amount in-hospital curve length end points reference diameter dissection serruys pw disease value angiogram multivariate multivariate analysis douglas js jr postangioplasty percent diameter stenosis assessment intervention diabetes infarction 7 months follow-up angiography reference stenting population hospital rensing eur heart j variability
4 Most Recent Publications
|
Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group.
(Article)
Macaya Miguel, C.M. Serruys, P.W.J.C. Crean, P.A. Bonnier, J.J.R.M. Wijns, W. Danchin, N. Bourdonnec, C. Morel, M-A.M. Mast, E.G. Ruygrok, P.N. Suryapranata, H. Klugmann, S. Urban, P. Heijer, P. den Koch, K. Simon, R. Morice, M-C. |
1996-02-01
|
|
Usefulness of quantitative and qualitative angiographic lesion morphology, and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty
(Article)
Hermans, W.R.M. Rensing, B.J.W.M. Balcon, R. Feyter, P.J. de Serruys, P.W.J.C. Foley, D.P. Rutsch, W.R. Heyndrickx, G.R. Danchin, N. Mast, E.G. Hanet, C. Lablanche, J.M. Rafflenbeul, W. Uebis, R. |
1993-07-01
|
|
Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to longterm angiographic outcome
(Article)
Rensing, B.J.W.M. Hermans, W.R.M. Vos, J.R. Tijssen, J.G.P. Rutsch, W.R. Danchin, N. Heyndrickx, G.R. Mast, E.G. Wijns, W. Serruys, P.W.J.C. |
1993-01-01
|
|
Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial
(Article)
Serruys, P.W.J.C. Rutsch, W.R. Heyndrickx, G.R. Danchin, N. Mast, E.G. Wijns, W. Rensing, B.J.W.M. Vos, J.R. Stibbe, J. |
1991-01-01
|
